CMS’ Limited Resources Hinder Ability To Implement Value-Based Purchasing
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Medicare & Medicaid Services' inability to fairly and accurately determine the "value" of a new device could deter the agency from utilizing value-based purchasing to pay for new technologies, according to MedPAC staff member Chantal Worzala, PhD